COMPANY PROFILE

Brightonix Imaging

Explore full profile

Global leader of innovative biomedical imaging solution

Seoul, South KoreaFounded 2016Biotech & Life Sciences

Valuation $100–250M Last recorded · 2025

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Brightonix Imaging

Brightonix Imaging is a pioneering company dedicated to advancing global health and happiness through innovative biomedical imaging devices and AI solutions. The company specializes in providing cutting-edge medical imaging AI solutions and SimPET, the most compact and reliable MRI-compatible SiPM PET insert for simultaneous PET MRI studies in small animals. Brightonix Imaging serves molecular imaging scientists and operates in the biomedical imaging market. The business model focuses on the development and sale of advanced imaging devices and AI solutions, generating revenue through product sales and specialized services.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Seoul, South Korea
Employees: 19
Open positions: None listed
Dealroom signal: 42.5/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Technology: Artificial Intelligence
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Nov 2025	$17M	$68M	Undisclosed	↗
SERIES A✓Equity / VC	May 2022	$5M	$20M	TS investment · Hana Ventures	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Brightonix Imaging website traffic

Latest recorded traffic for Brightonix Imaging is 2.8K monthly website visits, up 428.3% over the last three months. Brightonix Imaging's team grew 11.8% over the past year.

Latest monthly visits2.8K 3-month web change+428.3% 1-year team growth+11.8%

Monthly website visitsOct 2022–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
NONoetikAI-driven biotechnology company developing precision immunotherapies for cancer using advanced machine learning and human multimodal data	South San Francisco, United States	Operational	52	$54M	$160M
BABasgenbioVaszenio is a bio-vitator based on artificial intelligence that offers more than health value	Seoul, South Korea	Operational
AIAirBiometricsHelps to regain sovereignty over well-being	Castellón de la Plana, Spain	Operational
STSama TherapeuticsPrecision Neuropsychiatry AI/ML platform to accelerate psychedelic-inspired R&D	Cambridge, United States	Operational
MBMetaNovas BiotechCombines AI with cutting-edge science to decipher complex disease biology and discover effective medicines	Pudong, China	Operational
ETENSEM TherapeuticsBiotechnology company focusing on high value and difficult-to-drug oncology targets	Medford, United States	Operational
CTCongruence TherapeuticsBuilding the leading pharmacological stabilizer company for the treatment of rare diseases	Montreal, Canada	Operational
ZAZephyr AIThe world's most cutting-edge algorithms for advancing human health	Tysons, United States	Operational